EA202190891A1 - COMPOSITIONS AND METHODS FOR CONTROLLED OVARIAN STIMULATION - Google Patents
COMPOSITIONS AND METHODS FOR CONTROLLED OVARIAN STIMULATIONInfo
- Publication number
- EA202190891A1 EA202190891A1 EA202190891A EA202190891A EA202190891A1 EA 202190891 A1 EA202190891 A1 EA 202190891A1 EA 202190891 A EA202190891 A EA 202190891A EA 202190891 A EA202190891 A EA 202190891A EA 202190891 A1 EA202190891 A1 EA 202190891A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- compositions
- methods
- ovarian stimulation
- controlled ovarian
- controlled
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Описаны способы применения и композиции, включающие FSH для применения для лечения бесплодия, где дозу выбирают на основании возраста пациента для оптимизации кумулятивной эффективности и/или снижения риска развития OHSS.Described are methods of use and compositions comprising FSH for use in the treatment of infertility, where the dose is selected based on the age of the patient to optimize the cumulative efficacy and / or reduce the risk of OHSS.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP18203167 | 2018-10-29 | ||
PCT/EP2019/078170 WO2020079127A1 (en) | 2018-10-17 | 2019-10-17 | Compositions and methods for controlled ovarian stimulation |
Publications (1)
Publication Number | Publication Date |
---|---|
EA202190891A1 true EA202190891A1 (en) | 2021-07-12 |
Family
ID=64082983
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA202190891A EA202190891A1 (en) | 2018-10-29 | 2019-10-17 | COMPOSITIONS AND METHODS FOR CONTROLLED OVARIAN STIMULATION |
Country Status (1)
Country | Link |
---|---|
EA (1) | EA202190891A1 (en) |
-
2019
- 2019-10-17 EA EA202190891A patent/EA202190891A1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12020551923A1 (en) | Methods and compositions for treating cancer | |
MX2023007212A (en) | Epinephrine spray formulations. | |
EA201890009A1 (en) | EZH2 INHIBITORS FOR TREATING LYMPHOMA | |
EA201890725A1 (en) | PHARNESIDE X-RECEPTOR AGONISTS AND THEIR APPLICATION | |
EA201891268A1 (en) | COMPOUNDS WHICH CAN BE USED AS KINASE INHIBITORS | |
MX2019010040A (en) | Compositions and methods for treatment of cancer. | |
EA202091995A1 (en) | COMPOSITIONS AND METHODS FOR TREATMENT OF AGE-NON-AGE-RELATED HEARING IN A HUMAN SUBJECT | |
EA202191122A1 (en) | SELECTIVE TO RGMc INHIBITORS AND THEIR APPLICATION | |
JOP20190241B1 (en) | Epinephrine spray formulations | |
MX2021004755A (en) | Use of plasma and plasma fractions for improvement of pain, wound healing, and postoperative recovery. | |
EA201892297A1 (en) | METHODS FOR TREATING CHOLESTATIC AND FIBROTIC DISEASES | |
PH12021550122A1 (en) | Solubilized apyrases, methods and use | |
NZ762312A (en) | Anti-pacap antibody | |
MX2022006073A (en) | Methods of use of anti-trem2 antibodies. | |
JOP20210245A1 (en) | Methods of Treating AL Amyloidosis | |
EA202090260A1 (en) | MEANS AND METHODS FOR HUMAN AAV GENOTHERAPY | |
EA202090266A1 (en) | MPO INHIBITORS FOR MEDICAL USE | |
EA202191058A1 (en) | ANTIBODIES AGAINST MUCIN-16 AND METHODS OF THEIR APPLICATION | |
PH12021550417A1 (en) | Compositions and methods for controlled ovarian stimulation | |
EA202190891A1 (en) | COMPOSITIONS AND METHODS FOR CONTROLLED OVARIAN STIMULATION | |
EA201992852A1 (en) | DOSAGE DIAGRAM FOR TESETAXEL AND CAPETSITABINE | |
EA202090480A1 (en) | COMPOSITION FOR CONTROLLED OVARIAN STIMULATION | |
EA202190590A1 (en) | COMPOUNDS AND METHODS FOR TREATMENT OF FUNGAL INFECTIONS | |
MX2021002647A (en) | Methods of treating psoriasis. | |
EA202091802A1 (en) | BEXAROTENE DERIVATIVES AND THEIR USE FOR CANCER TREATMENT |